AstraZeneca trial failure raises bigger questions about its portfolio
AstraZenecaWainua's failed final trial was never expected to have a major financial impact on the company. Most analysts estimate that…
Health
Discover the Latest Health, Medicine, Nutrition, and Fitness Tips for Women, Men, and Children
Journalists debate raw milk marketing, extreme heat and spending on opioid deals
Céline Gounder, public health editor-at-large for KFF Health News, discussed the health risks of consuming raw milk and an outbreak…
New cholera outbreak alert for war-weary Sudanese communities
“Cholera has returned and affects several statesmainly in the western part of the country, Darfur and Kordofan,” said Dr. Shible…
Abivax receives $920 million in cash to prepare for US launch: CEO
AbivaxThe latest round of funding allows the biotech to move toward launching its intestinal disease drug in the United States…
Cancer cases could almost double by 2050 if urgent action is not taken, warns WHO
That's the headline emerging from a new report from the UN health agency that highlights stark inequalities in cancer survival…
AstraZeneca shares fall 9% after heart drug trial falls short of target
Actions of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease drug failed to…
Lawmakers target power of health insurance giants
After years of unbridled expansion in nearly every corner of the health care system, the largest insurance conglomerates are facing…
Affordable Care Act insurers want more premium increases as enrollment declines
For the second year in a row, many insurers under the Affordable Care Act are proposing double-digit premium increases, driven…
Ebola continues to spread in the Democratic Republic of the Congo as the death toll surpasses 500, WHO warns
The “true scale of the outbreak has not yet been fully established,” said Dr. Anne Ancia, WHO representative in the…
Jim Cramer Says These Are the 5 Stocks to Buy During This Market Rotation
CNBC's Jim Cramer said Monday that investors should not fear the latest market rotation. Instead, he believes he is creating…